{"id": "article-24379_0", "title": "Liver Toxicity -- Continuing Education Activity", "content": "One of the most important causes of liver dysfunction is drug-induced liver injury (DILI) which can lead to a wide spectrum of symptoms ranging from mild non-specific symptoms like asymptomatic transaminitis, acute hepatitis, chronic hepatitis, cholestasis to liver failure. It can be caused by a multitude of prescription drugs, herbal and dietary supplements and commonly leads to withdrawal of the drug from the market. This activity reviews the cause of liver toxicity, the pathophysiology, presentation and highlights the role of the interprofessional team in the management of these patients.", "contents": "Liver Toxicity -- Continuing Education Activity. One of the most important causes of liver dysfunction is drug-induced liver injury (DILI) which can lead to a wide spectrum of symptoms ranging from mild non-specific symptoms like asymptomatic transaminitis, acute hepatitis, chronic hepatitis, cholestasis to liver failure. It can be caused by a multitude of prescription drugs, herbal and dietary supplements and commonly leads to withdrawal of the drug from the market. This activity reviews the cause of liver toxicity, the pathophysiology, presentation and highlights the role of the interprofessional team in the management of these patients."}
{"id": "article-24379_1", "title": "Liver Toxicity -- Continuing Education Activity", "content": "Objectives: Review the drugs that can cause liver toxicity. Describe the pathophysiology of drug induced liver damage. Summarize the evaluation of patients with drug induced liver toxicity. Outline the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by liver toxicity Access free multiple choice questions on this topic.", "contents": "Liver Toxicity -- Continuing Education Activity. Objectives: Review the drugs that can cause liver toxicity. Describe the pathophysiology of drug induced liver damage. Summarize the evaluation of patients with drug induced liver toxicity. Outline the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by liver toxicity Access free multiple choice questions on this topic."}
{"id": "article-24379_2", "title": "Liver Toxicity -- Introduction", "content": "One of the most important causes of liver dysfunction is drug-induced liver injury (DILI) which can lead to a wide spectrum of symptoms ranging from mild non-specific symptoms like asymptomatic transaminitis, acute hepatitis, chronic hepatitis, cholestasis to liver failure. [1] It can be caused by a multitude of prescription drugs, herbal and dietary supplements and\u00a0commonly leads to withdrawal of the drug from the market. [2]", "contents": "Liver Toxicity -- Introduction. One of the most important causes of liver dysfunction is drug-induced liver injury (DILI) which can lead to a wide spectrum of symptoms ranging from mild non-specific symptoms like asymptomatic transaminitis, acute hepatitis, chronic hepatitis, cholestasis to liver failure. [1] It can be caused by a multitude of prescription drugs, herbal and dietary supplements and\u00a0commonly leads to withdrawal of the drug from the market. [2]"}
{"id": "article-24379_3", "title": "Liver Toxicity -- Etiology", "content": "There are many classes of drugs causing drug-induced liver injury including nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infective drugs\u00a0(anti-tubercular drugs), anti-cancer drugs, hormonal drugs, immunosuppressive agents, sedative, and neuropsychiatric drugs. [3] The most common drug implicated in\u00a0drug-induced liver injury\u00a0is acetaminophen. [4] Antibiotics are the class of drugs most commonly causing liver toxicity, [5] and amoxicillin-clavulanate stands out as the most common drug in this class. [6] Additionally, herbal supplements cause a variety of symptoms, but their usage remains under-reported. [7] The NIH LiverTox website is an online resource that provides comprehensive information about\u00a0drug-induced liver injury\u00a0caused by prescription drugs and dietary and herbal supplements.", "contents": "Liver Toxicity -- Etiology. There are many classes of drugs causing drug-induced liver injury including nonsteroidal anti-inflammatory drugs (NSAIDs), anti-infective drugs\u00a0(anti-tubercular drugs), anti-cancer drugs, hormonal drugs, immunosuppressive agents, sedative, and neuropsychiatric drugs. [3] The most common drug implicated in\u00a0drug-induced liver injury\u00a0is acetaminophen. [4] Antibiotics are the class of drugs most commonly causing liver toxicity, [5] and amoxicillin-clavulanate stands out as the most common drug in this class. [6] Additionally, herbal supplements cause a variety of symptoms, but their usage remains under-reported. [7] The NIH LiverTox website is an online resource that provides comprehensive information about\u00a0drug-induced liver injury\u00a0caused by prescription drugs and dietary and herbal supplements."}
{"id": "article-24379_4", "title": "Liver Toxicity -- Epidemiology", "content": "Drug-induced liver injury is the most common cause of acute liver failure (ALF) in the United States and Europe [8] and accounts for 20% to 40% of all instances of fulminant hepatic failure. [9] Although the incidence of\u00a0drug-induced liver injury\u00a0has been reported to be as low as 1 in 10,000 to 100,000, [10] the absolute incidence of\u00a0drug-induced liver injury\u00a0is still unknown as many cases are missed or underreported. [11] It is also difficult to confidently ascribe hepatic injury to a drug because currently,\u00a0there are no universally accepted guidelines to assess\u00a0drug-induced liver injury.\u00a0Drug-Induced Liver Injury Network has been established\u00a0in the United States since 2003 to understand the causes, risk factors, and outcomes of\u00a0drug-induced liver injury\u00a0by collecting and analyzing suspected cases. [12] Multiple risk factors like old age, female gender, chronic alcoholism, and pregnancy have been described in the literature\u00a0to cause an increased risk of\u00a0drug-induced liver injury. However, some studies have revealed these factors do\u00a0pose a higher risk to specific drugs and not all-cause liver toxicity (liver toxicity caused by all drugs). For example, children are at an increased risk of liver toxicity caused by valproate and are more prone to\u00a0Reye syndrome with aspirin. But with increasing age, the risk of toxicity increases with drugs like amoxicillin-clavulanate. [13] Some HLA types (human leukocyte antigen) serotypes have been identified as risk factors for\u00a0drug-induced liver injury. [14]", "contents": "Liver Toxicity -- Epidemiology. Drug-induced liver injury is the most common cause of acute liver failure (ALF) in the United States and Europe [8] and accounts for 20% to 40% of all instances of fulminant hepatic failure. [9] Although the incidence of\u00a0drug-induced liver injury\u00a0has been reported to be as low as 1 in 10,000 to 100,000, [10] the absolute incidence of\u00a0drug-induced liver injury\u00a0is still unknown as many cases are missed or underreported. [11] It is also difficult to confidently ascribe hepatic injury to a drug because currently,\u00a0there are no universally accepted guidelines to assess\u00a0drug-induced liver injury.\u00a0Drug-Induced Liver Injury Network has been established\u00a0in the United States since 2003 to understand the causes, risk factors, and outcomes of\u00a0drug-induced liver injury\u00a0by collecting and analyzing suspected cases. [12] Multiple risk factors like old age, female gender, chronic alcoholism, and pregnancy have been described in the literature\u00a0to cause an increased risk of\u00a0drug-induced liver injury. However, some studies have revealed these factors do\u00a0pose a higher risk to specific drugs and not all-cause liver toxicity (liver toxicity caused by all drugs). For example, children are at an increased risk of liver toxicity caused by valproate and are more prone to\u00a0Reye syndrome with aspirin. But with increasing age, the risk of toxicity increases with drugs like amoxicillin-clavulanate. [13] Some HLA types (human leukocyte antigen) serotypes have been identified as risk factors for\u00a0drug-induced liver injury. [14]"}
{"id": "article-24379_5", "title": "Liver Toxicity -- Pathophysiology", "content": "Liver\u00a0damage can be hepatocellular, cholestatic, or mixed (includes features of both). [6] Cholestatic damage commonly occurs due to the drug or the drug metabolite. They inhibit hepatobiliary transporter systems which are\u00a0essential for bile formation and secretion of cholephilic substances and xenobiotics. [15] Hepatocellular occurs through multiple pathways including direct hepatotoxicity, and innate and adaptive immune responses. [8] Drug-induced liver injury\u00a0can be dose-dependent/intrinsic, and on most occasions, it is dose-independent/idiosyncratic. Acetaminophen usually causes\u00a0drug-induced liver injury\u00a0in a dose-dependent\u00a0fashion. Most other drugs cause a dose-independent pattern of hepatotoxicity. [16]", "contents": "Liver Toxicity -- Pathophysiology. Liver\u00a0damage can be hepatocellular, cholestatic, or mixed (includes features of both). [6] Cholestatic damage commonly occurs due to the drug or the drug metabolite. They inhibit hepatobiliary transporter systems which are\u00a0essential for bile formation and secretion of cholephilic substances and xenobiotics. [15] Hepatocellular occurs through multiple pathways including direct hepatotoxicity, and innate and adaptive immune responses. [8] Drug-induced liver injury\u00a0can be dose-dependent/intrinsic, and on most occasions, it is dose-independent/idiosyncratic. Acetaminophen usually causes\u00a0drug-induced liver injury\u00a0in a dose-dependent\u00a0fashion. Most other drugs cause a dose-independent pattern of hepatotoxicity. [16]"}
{"id": "article-24379_6", "title": "Liver Toxicity -- Histopathology", "content": "Similar to the clinical patterns,\u00a0drug-induced liver injury\u00a0can present in different histopathologic manifestations. It can cause acute and chronic hepatocellular pattern of injury. Acute hepatocellular usually resembles that of acute hepatitis while chronic hepatocellular\u00a0patterns usually resemble that of chronic hepatitis, autoimmune hepatitis, fibrosis, and cirrhosis. A cholestatic pattern shows cholestasis. Some cause steatosis and steatohepatitis pattern resembling that of alcoholic\u00a0fatty liver disease or nonalcoholic fatty liver disease. It can also present as granulomas, various vascular injury patterns, cytoplasmic inclusions, lipidosis and pigments, and drug-induced\u00a0neoplasms. [16]", "contents": "Liver Toxicity -- Histopathology. Similar to the clinical patterns,\u00a0drug-induced liver injury\u00a0can present in different histopathologic manifestations. It can cause acute and chronic hepatocellular pattern of injury. Acute hepatocellular usually resembles that of acute hepatitis while chronic hepatocellular\u00a0patterns usually resemble that of chronic hepatitis, autoimmune hepatitis, fibrosis, and cirrhosis. A cholestatic pattern shows cholestasis. Some cause steatosis and steatohepatitis pattern resembling that of alcoholic\u00a0fatty liver disease or nonalcoholic fatty liver disease. It can also present as granulomas, various vascular injury patterns, cytoplasmic inclusions, lipidosis and pigments, and drug-induced\u00a0neoplasms. [16]"}
{"id": "article-24379_7", "title": "Liver Toxicity -- History and Physical", "content": "Some patients present with fatigue, decreased appetite, aversion to oily food, epigastric discomfort and tender liver. Patients with cholestatic type can present with jaundice, light colored faeces and pruritis. Occasionally, they can also have allergic manifestations like fever, rash and aching in joints. [3]", "contents": "Liver Toxicity -- History and Physical. Some patients present with fatigue, decreased appetite, aversion to oily food, epigastric discomfort and tender liver. Patients with cholestatic type can present with jaundice, light colored faeces and pruritis. Occasionally, they can also have allergic manifestations like fever, rash and aching in joints. [3]"}
{"id": "article-24379_8", "title": "Liver Toxicity -- Evaluation", "content": "In most cases,\u00a0drug-induced liver injury\u00a0may cause mild to moderate elevation of liver tests, but in rare cases, it can lead to fatal outcomes. [17] It can cause elevation of liver enzymes including alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), and total bilirubin. [8] However, there is currently\u00a0no single test that can predict DILI. [8] Patients with allergic manifestation can have eosinophilia and elevated autoantibodies. [18] Chronic,\u00a0drug-induced liver injury\u00a0can present with different manifestations including chronic hepatitis, liver fibrosis, cirrhosis. [3] Elevated serum bilirubin, low albumin, and blood coagulation defects signify severe liver damage. [3] Also, hepatocellular\u00a0drug-induced liver injury\u00a0causes more elevation of ALT\u00a0as compared to ALP and\u00a0vice-versa in the case of cholestatic. [18] In 2011, the International Serious Adverse Events Consortium (iSAEC) recommended\u00a0modified biochemical criteria for identification of\u00a0drug-induced liver injury\u00a0as reaching any of the following items [19] :", "contents": "Liver Toxicity -- Evaluation. In most cases,\u00a0drug-induced liver injury\u00a0may cause mild to moderate elevation of liver tests, but in rare cases, it can lead to fatal outcomes. [17] It can cause elevation of liver enzymes including alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), and total bilirubin. [8] However, there is currently\u00a0no single test that can predict DILI. [8] Patients with allergic manifestation can have eosinophilia and elevated autoantibodies. [18] Chronic,\u00a0drug-induced liver injury\u00a0can present with different manifestations including chronic hepatitis, liver fibrosis, cirrhosis. [3] Elevated serum bilirubin, low albumin, and blood coagulation defects signify severe liver damage. [3] Also, hepatocellular\u00a0drug-induced liver injury\u00a0causes more elevation of ALT\u00a0as compared to ALP and\u00a0vice-versa in the case of cholestatic. [18] In 2011, the International Serious Adverse Events Consortium (iSAEC) recommended\u00a0modified biochemical criteria for identification of\u00a0drug-induced liver injury\u00a0as reaching any of the following items [19] :"}
{"id": "article-24379_9", "title": "Liver Toxicity -- Evaluation", "content": "Alanine transferase greater than or equal to 5 ULN Alkaline Phosphatase greater than or equal to 2 ULN, especially in patients with elevated 5'-nucleotidase or GGT, and without bone-diseases-related ALP elevation Alanine transferase greater than or equal to 3 ULN and total bilirubin greater than or equal to 2 ULN", "contents": "Liver Toxicity -- Evaluation. Alanine transferase greater than or equal to 5 ULN Alkaline Phosphatase greater than or equal to 2 ULN, especially in patients with elevated 5'-nucleotidase or GGT, and without bone-diseases-related ALP elevation Alanine transferase greater than or equal to 3 ULN and total bilirubin greater than or equal to 2 ULN"}
{"id": "article-24379_10", "title": "Liver Toxicity -- Evaluation", "content": "This\u00a0recommendation was\u00a0given\u00a0to avoid unnecessary drug withdrawals. But it is difficult to\u00a0confidently ascribe\u00a0at times\u00a0whether it is\u00a0drug-induced liver injury\u00a0or aggravation of a\u00a0pre-existing liver injury. [3] Generally, the elevation of liver tests can be attributed to\u00a0drug-induced liver injury\u00a0when there is preceding history of drug exposure, discontinuation of the drug leads to improvement in liver injury, recurrence on rechallenge and the drug does have a history of causing drug-induced liver injury\u00a0in other patients. [20]", "contents": "Liver Toxicity -- Evaluation. This\u00a0recommendation was\u00a0given\u00a0to avoid unnecessary drug withdrawals. But it is difficult to\u00a0confidently ascribe\u00a0at times\u00a0whether it is\u00a0drug-induced liver injury\u00a0or aggravation of a\u00a0pre-existing liver injury. [3] Generally, the elevation of liver tests can be attributed to\u00a0drug-induced liver injury\u00a0when there is preceding history of drug exposure, discontinuation of the drug leads to improvement in liver injury, recurrence on rechallenge and the drug does have a history of causing drug-induced liver injury\u00a0in other patients. [20]"}
{"id": "article-24379_11", "title": "Liver Toxicity -- Treatment / Management", "content": "Discontinuing the suspected drug is the first step in the management of\u00a0drug-induced liver injury. [3] N-acetylcysteine is the antidote for acetaminophen poisoning. However, intravenous N- acetylcysteine has been shown to improve survival with non-acetaminophen-related acute liver failure. [21] Carnitine has been used in valproate injury. Steroids have been proposed as a therapeutic option for liver injury but have not been well studied. [22] Currently, glucocorticoids are used for immune-mediated\u00a0drug-induced liver injury. [3] Silymarin alone or silymarin combination with benzylpenicillin has been used in mushroom toxicity, but their efficacy has not yet been well studied. [23] In patients with cholestasis, ursodeoxycholic acid can be tried. [11] Antihistamines can\u00a0be used in case of pruritis. [14] Patients should be followed until\u00a0the resolution of symptoms and normalization of labs. [14]", "contents": "Liver Toxicity -- Treatment / Management. Discontinuing the suspected drug is the first step in the management of\u00a0drug-induced liver injury. [3] N-acetylcysteine is the antidote for acetaminophen poisoning. However, intravenous N- acetylcysteine has been shown to improve survival with non-acetaminophen-related acute liver failure. [21] Carnitine has been used in valproate injury. Steroids have been proposed as a therapeutic option for liver injury but have not been well studied. [22] Currently, glucocorticoids are used for immune-mediated\u00a0drug-induced liver injury. [3] Silymarin alone or silymarin combination with benzylpenicillin has been used in mushroom toxicity, but their efficacy has not yet been well studied. [23] In patients with cholestasis, ursodeoxycholic acid can be tried. [11] Antihistamines can\u00a0be used in case of pruritis. [14] Patients should be followed until\u00a0the resolution of symptoms and normalization of labs. [14]"}
{"id": "article-24379_12", "title": "Liver Toxicity -- Differential Diagnosis", "content": "The diagnosis of\u00a0drug-induced liver injury\u00a0is a challenge because it can mimic any form of liver disease. [20] Exclusion of other possible\u00a0causes is important for diagnosis depending upon the pattern of liver injury. [12] Drug-induced liver injury\u00a0presents with an elevation of liver tests, which has numerous causes. All causes of hepatitis-like viral hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease, and autoimmune hepatitis should be ruled out. Causes of cholestasis like biliary obstruction, primary biliary cirrhosis, and\u00a0primary sclerosing cholangitis should be considered when evaluating a patient.", "contents": "Liver Toxicity -- Differential Diagnosis. The diagnosis of\u00a0drug-induced liver injury\u00a0is a challenge because it can mimic any form of liver disease. [20] Exclusion of other possible\u00a0causes is important for diagnosis depending upon the pattern of liver injury. [12] Drug-induced liver injury\u00a0presents with an elevation of liver tests, which has numerous causes. All causes of hepatitis-like viral hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease, and autoimmune hepatitis should be ruled out. Causes of cholestasis like biliary obstruction, primary biliary cirrhosis, and\u00a0primary sclerosing cholangitis should be considered when evaluating a patient."}
{"id": "article-24379_13", "title": "Liver Toxicity -- Prognosis", "content": "Most of the patients of\u00a0drug-induced liver injury\u00a0have a favorable prognosis. [3] Some patients have prolonged cholestasis even after the offending drug is withdrawn. [24] It will generally\u00a0resolve 3 to 12 months after withdrawal of the offending drug, but some patients have prolonged course and may develop vanishing bile duct syndrome and cholestatic cirrhosis, which have a poor prognosis. [3] The AST and bilirubin levels signify prognosis in terms of death and liver transplants. [25] Drug-induced liver injury\u00a0can cause chronic liver disease and the risk\u00a0usually\u00a0increases with cholestatic or mixed type compared to hepatocellular type. [26]", "contents": "Liver Toxicity -- Prognosis. Most of the patients of\u00a0drug-induced liver injury\u00a0have a favorable prognosis. [3] Some patients have prolonged cholestasis even after the offending drug is withdrawn. [24] It will generally\u00a0resolve 3 to 12 months after withdrawal of the offending drug, but some patients have prolonged course and may develop vanishing bile duct syndrome and cholestatic cirrhosis, which have a poor prognosis. [3] The AST and bilirubin levels signify prognosis in terms of death and liver transplants. [25] Drug-induced liver injury\u00a0can cause chronic liver disease and the risk\u00a0usually\u00a0increases with cholestatic or mixed type compared to hepatocellular type. [26]"}
{"id": "article-24379_14", "title": "Liver Toxicity -- Complications", "content": "Acute Respiratory failure Acute liver failure Acute renal failure Severe metabolic acidosis", "contents": "Liver Toxicity -- Complications. Acute Respiratory failure Acute liver failure Acute renal failure Severe metabolic acidosis"}
{"id": "article-24379_15", "title": "Liver Toxicity -- Consultations", "content": "Intensive care and consideration of\u00a0transfer\u00a0to advanced centers should be done in case of advanced disease. [11]", "contents": "Liver Toxicity -- Consultations. Intensive care and consideration of\u00a0transfer\u00a0to advanced centers should be done in case of advanced disease. [11]"}
{"id": "article-24379_16", "title": "Liver Toxicity -- Deterrence and Patient Education", "content": "Many of the herbal supplements, dietary supplements and other over the counter medications are often associated with liver injury which can lead to complications especially in patients with underlying liver disease. It is important to discuss with your primary care provider before starting on any herbal or dietary supplements. It is also important to go over the medications you are taking with you doctor to see if the supplements have interactions with the medications you are taking which ma lead to serious liver injury.", "contents": "Liver Toxicity -- Deterrence and Patient Education. Many of the herbal supplements, dietary supplements and other over the counter medications are often associated with liver injury which can lead to complications especially in patients with underlying liver disease. It is important to discuss with your primary care provider before starting on any herbal or dietary supplements. It is also important to go over the medications you are taking with you doctor to see if the supplements have interactions with the medications you are taking which ma lead to serious liver injury."}
{"id": "article-24379_17", "title": "Liver Toxicity -- Pearls and Other Issues", "content": "Drug-induced liver injury is an uncommon but important form of liver disease. When evaluating a patient for liver disease,\u00a0drug-induced liver injury\u00a0must always be considered as a possible\u00a0cause of liver disease as it\u00a0can be severe and even fatal. It can present in a pattern similar to acute hepatitis, biliary obstruction, chronic hepatitis, acute liver disease or fatty liver disease. Drug-induced liver injury\u00a0is usually reversible, and the first step in its management is discontinuing the drug. However,\u00a0drug-induced liver injury\u00a0is a challenging form of liver disease because of the ever increasing number of drugs used in medical care. Hundreds of drugs have been implicated as the cause. Many of the herbal supplements, dietary supplements and other over the counter medications are often underreported. A lot of research in this field is being undertaken, and there is scope for more.", "contents": "Liver Toxicity -- Pearls and Other Issues. Drug-induced liver injury is an uncommon but important form of liver disease. When evaluating a patient for liver disease,\u00a0drug-induced liver injury\u00a0must always be considered as a possible\u00a0cause of liver disease as it\u00a0can be severe and even fatal. It can present in a pattern similar to acute hepatitis, biliary obstruction, chronic hepatitis, acute liver disease or fatty liver disease. Drug-induced liver injury\u00a0is usually reversible, and the first step in its management is discontinuing the drug. However,\u00a0drug-induced liver injury\u00a0is a challenging form of liver disease because of the ever increasing number of drugs used in medical care. Hundreds of drugs have been implicated as the cause. Many of the herbal supplements, dietary supplements and other over the counter medications are often underreported. A lot of research in this field is being undertaken, and there is scope for more."}
{"id": "article-24379_18", "title": "Liver Toxicity -- Enhancing Healthcare Team Outcomes", "content": "Drug-induced liver injury\u00a0can be prevented by educating patients by the clinician once starting them on hepatotoxic drugs and warning them about possible side effects. Clinical judgment on the part of clinician and balancing risks versus benefits when starting patients on drugs with the potential to be hepatotoxic are needed. The warnings about the possible presentations of\u00a0drug-induced liver injury\u00a0should be\u00a0clearly\u00a0stated on the medication. It also involves reporting\u00a0drugs that are suspected to cause liver toxicity\u00a0as well as regulatory bodies like FDA to take appropriate steps to withdraw the drugs from the market based on data. The National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health has developed Drug-Induced Liver Injury Network, which constitutes 6 university hospitals working to collect and analyze data. (Level V)", "contents": "Liver Toxicity -- Enhancing Healthcare Team Outcomes. Drug-induced liver injury\u00a0can be prevented by educating patients by the clinician once starting them on hepatotoxic drugs and warning them about possible side effects. Clinical judgment on the part of clinician and balancing risks versus benefits when starting patients on drugs with the potential to be hepatotoxic are needed. The warnings about the possible presentations of\u00a0drug-induced liver injury\u00a0should be\u00a0clearly\u00a0stated on the medication. It also involves reporting\u00a0drugs that are suspected to cause liver toxicity\u00a0as well as regulatory bodies like FDA to take appropriate steps to withdraw the drugs from the market based on data. The National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health has developed Drug-Induced Liver Injury Network, which constitutes 6 university hospitals working to collect and analyze data. (Level V)"}
{"id": "article-24379_19", "title": "Liver Toxicity -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Liver Toxicity -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}